These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7651642)

  • 1. Improving compliance among women with abnormal Papanicolaou smears.
    Paskett ED; Phillips KC; Miller ME
    Obstet Gynecol; 1995 Sep; 86(3):353-9. PubMed ID: 7651642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of educational brochures on knowledge and emotional distress in women with abnormal Papanicolaou smears.
    Stewart DE; Lickrish GM; Sierra S; Parkin H
    Obstet Gynecol; 1993 Feb; 81(2):280-2. PubMed ID: 8423964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Women with human immunodeficiency virus infection and abnormal Papanicolaou smears: a prospective study of colposcopy and clinical outcome.
    Adachi A; Fleming I; Burk RD; Ho GY; Klein RS
    Obstet Gynecol; 1993 Mar; 81(3):372-7. PubMed ID: 8437789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of a call/recall system in improving compliance with cervical cancer screening: a randomized controlled trial.
    Buehler SK; Parsons WL
    CMAJ; 1997 Sep; 157(5):521-6. PubMed ID: 9294390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding barriers for adherence to follow-up care for abnormal pap tests.
    Eggleston KS; Coker AL; Das IP; Cordray ST; Luchok KJ
    J Womens Health (Larchmt); 2007 Apr; 16(3):311-30. PubMed ID: 17439377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of educational brochures on follow-up compliance in women with abnormal Papanicolaou smears.
    Stewart DE; Buchegger PM; Lickrish GM; Sierra S
    Obstet Gynecol; 1994 Apr; 83(4):583-5. PubMed ID: 8134070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timing of the postpartum Papanicolaou smear.
    Rarick TL; Tchabo JG
    Obstet Gynecol; 1994 May; 83(5 Pt 1):761-5. PubMed ID: 8164940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appraisal of the modalities used to evaluate an initial abnormal Papanicolaou smear.
    Higgins RV; Hall JB; McGee JA; Laurent S; Alvarez RD; Partridge EE
    Obstet Gynecol; 1994 Aug; 84(2):174-8. PubMed ID: 8041525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The colposcopic impression. Is it influenced by the colposcopist's knowledge of the findings on the referral Papanicolaou smear?
    Pretorius RG; Belinson JL; Zhang WH; Burchette RJ; Elson P; Qiao YL
    J Reprod Med; 2001 Aug; 46(8):724-8. PubMed ID: 11547646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving follow-up after an abnormal Pap smear: a randomized controlled trial.
    Paskett ED; White E; Carter WB; Chu J
    Prev Med; 1990 Nov; 19(6):630-41. PubMed ID: 2263574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytopathologic changes associated with intrauterine contraceptive devices. A review of cervico-vaginal smears in 350 women.
    Pillay B; Gregory AR; Subbiah M
    Med J Malaysia; 1994 Mar; 49(1):74-7. PubMed ID: 8057995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Informational needs and the experiences of women with abnormal Papanicolaou smears.
    Bertram CC; Magnussen L
    J Am Acad Nurse Pract; 2008 Sep; 20(9):455-62. PubMed ID: 18786022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of women with abnormal cervical cytology: treatment patterns and associated costs in England and Wales.
    Martin-Hirsch P; Rash B; Martin A; Standaert B
    BJOG; 2007 Apr; 114(4):408-15. PubMed ID: 17378815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations in breast and colon cancer screening behavior in women.
    Carlos RC; Fendrick AM; Patterson SK; Bernstein SJ
    Acad Radiol; 2005 Apr; 12(4):451-8. PubMed ID: 15831418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving adherence to screening follow-up among women with abnormal Pap smears: results from a large clinic-based trial of three intervention strategies.
    Marcus AC; Crane LA; Kaplan CP; Reading AE; Savage E; Gunning J; Bernstein G; Berek JS
    Med Care; 1992 Mar; 30(3):216-30. PubMed ID: 1538610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A computerized reminder system improves compliance with Papanicolaou smear recommendations in an HIV care clinic.
    Shuter J; Kalkut GE; Pinon MW; Bellin EY; Zingman BS
    Int J STD AIDS; 2003 Oct; 14(10):675-80. PubMed ID: 14596771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysplasia severity, but not experiences during colposcopy, predicts adherence to follow-up colposcopy.
    Kola S; Walsh JC
    Psychooncology; 2012 Mar; 21(3):291-6. PubMed ID: 22383271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetic acid visualization of the cervix to detect cervical dysplasia.
    Van Le L; Broekhuizen FF; Janzer-Steele R; Behar M; Samter T
    Obstet Gynecol; 1993 Feb; 81(2):293-5. PubMed ID: 8423967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inflammatory Papanicolaou smear: what does it mean?
    Eckert LO; Koutsky LA; Kiviat NB; Krone MR; Stevens CE; Eschenbach DA
    Obstet Gynecol; 1995 Sep; 86(3):360-6. PubMed ID: 7651643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of cytologic follow-up as the recommended management for patients with atypical squamous cells of undetermined significance or low grade squamous intraepithelial lesions.
    Alanen KW; Elit LM; Molinaro PA; McLachlin CM
    Cancer; 1998 Feb; 84(1):5-10. PubMed ID: 9500646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.